Sundus Ayesha, Siddique Osama, Ibrahim Mohammad Faisal, Abbasi Zohaib, Aziz Sina
Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
Department of Paediatrics, Abbasi Shaheed Hospital Karachi, Pakistan.
J Pak Med Assoc. 2013 Dec;63(12):1566-70.
To investigate the causes for loss-to-follow-up of hepatitis patients at a liver centre of a tertiary care hospital.
A representative sample of 165 patients who were lost to follow-up during 2009 to 2010 was chosen and a cross-sectional descriptive study was performed. All hepatitis patients included were screened for antibody to hepatitis C virus (HCV Ab) and hepatitis B virus surface antigen (HbsAg), and were tested through polymerase chain reaction (PCR) and genotyping. Laboratory investigations, ultrasounds, personal habits, visits to hakeems and use of other alternative medications, occupations and income per month, education, and other basic information was also recorded. Those who did not return for follow-up were contacted and inquired about their reasons for loss-to-follow-up. Based on this data, the patients were categorised into four different groups according to reasons of loss to follow up: non-compliance, alternative medication, monetary issue and poor prognosis.
The entire sample size of 165 patients who were lost to follow-up was included in the study. 14 (8.5%) patients were hepatitis B virus (HBV) positive. Of these patients, 1 (7.1%) was lost due to alternative medication and the rest (n=13; 92.9%) were lost to follow-up due to non-compliance. Amongst the 151 (91.5%) hepatitis C virus (HCV) positive patients, 2 (1.3%) were lost due to monetary issues, 17 (11.3%) were lost due to alternative medication, 4 (2.6%) were lost due to poor prognosis and 128 (84.8%) were lost due to non-compliance.
This study shows that most patients were lost to follow-up due to non-compliance. It is important for physicians to design better counselling programmes to make the patient compliant enough to go through the complete treatment.
调查一家三级护理医院肝脏中心肝炎患者失访的原因。
选取2009年至2010年期间失访的165例患者作为代表性样本,进行横断面描述性研究。纳入的所有肝炎患者均接受丙型肝炎病毒抗体(HCV Ab)和乙型肝炎病毒表面抗原(HbsAg)筛查,并通过聚合酶链反应(PCR)和基因分型进行检测。还记录了实验室检查、超声检查、个人习惯、看哈基姆医生的情况及使用其他替代药物的情况、职业和月收入、教育程度及其他基本信息。对未回来进行随访的患者进行联系,询问其失访原因。根据这些数据,将患者按失访原因分为四类:不依从、使用替代药物、经济问题和预后不良。
研究纳入了全部165例失访患者样本。14例(8.5%)患者乙型肝炎病毒(HBV)呈阳性。其中,1例(7.1%)因使用替代药物而失访,其余13例(92.9%)因不依从而失访。在151例(91.5%)丙型肝炎病毒(HCV)呈阳性的患者中,2例(1.3%)因经济问题失访,17例(11.3%)因使用替代药物失访,4例(2.6%)因预后不良失访,128例(84.8%)因不依从失访。
本研究表明,大多数患者因不依从而失访。医生设计更好的咨询方案以使患者足够依从以完成整个治疗非常重要。